These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1115 related items for PubMed ID: 29759518

  • 41. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B, Reek S, Saguner AM, Krasniqi N, Eriksson U, Duru F.
    Swiss Med Wkly; 2019 Nov 04; 149():w20136. PubMed ID: 31707723
    [Abstract] [Full Text] [Related]

  • 42. Causes and clinical consequences of inappropriate shocks experienced by patients wearing a cardioverter-defibrillator.
    Berger JM, Sengupta JD, Bank AJ, Casey SA, Witt D, Sharkey SW, Stanberry LI, Hauser RG.
    Heart Rhythm; 2023 Jul 04; 20(7):970-975. PubMed ID: 37211148
    [Abstract] [Full Text] [Related]

  • 43. The wearable cardioverter-defibrillator vest: Indications and ongoing questions.
    Sandhu U, Rajyaguru C, Cheung CC, Morin DP, Lee BK.
    Prog Cardiovasc Dis; 2019 Jul 04; 62(3):256-264. PubMed ID: 31077726
    [Abstract] [Full Text] [Related]

  • 44. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B, Kühne M, Reichlin T, Osswald S, Sticherling C.
    Europace; 2016 Feb 04; 18(2):227-31. PubMed ID: 26063686
    [Abstract] [Full Text] [Related]

  • 45. The impact of body mass index on the wearable cardioverter defibrillator shock efficacy and patient wear time.
    Wan C, Szymkiewicz SJ, Klein HU.
    Am Heart J; 2017 Apr 04; 186():111-117. PubMed ID: 28454824
    [Abstract] [Full Text] [Related]

  • 46. A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest.
    Hummel J, Houmsse M, Tomassoni G, Nair D, Romero J, Hargrove J, Mathews K, Thakkar AB, Ullery S, Eapen ZJ, Kumar UN, Mehran R, Butler J, Jewel IDE Study Investigators.
    J Am Coll Cardiol; 2024 Aug 06; 84(6):525-536. PubMed ID: 39084827
    [Abstract] [Full Text] [Related]

  • 47. Prior history of atrial fibrillation and arrhythmic outcomes: Data from the WEARIT-II prospective registry.
    Goldenberg I, Younis A, McNitt S, Klein H, Goldenberg I, Kutyifa V.
    J Cardiovasc Electrophysiol; 2024 Apr 06; 35(4):785-793. PubMed ID: 38383981
    [Abstract] [Full Text] [Related]

  • 48. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ.
    J Am Coll Cardiol; 1999 May 06; 33(6):1596-601. PubMed ID: 10334430
    [Abstract] [Full Text] [Related]

  • 49. Keeping up to date: a current review of wearable cardioverter defibrillator use.
    Ashraf S, Ilyas S, Siddiqui F, Ando T, Shokr M, Panaich S, Briasoulis A, Afonso L, Khan M.
    Acta Cardiol; 2020 Dec 06; 75(8):695-704. PubMed ID: 31687917
    [Abstract] [Full Text] [Related]

  • 50. Cost-minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: Clinical and economic implications.
    Boriani G, Mantovani LG, Cortesi PA, De Ponti R, D'Onofrio A, Arena G, Curnis A, Forleo G, Guerra F, Porcu M, Sgarito G, Botto GL.
    Clin Cardiol; 2021 Nov 06; 44(11):1497-1505. PubMed ID: 34427926
    [Abstract] [Full Text] [Related]

  • 51. Experience With Wearable Cardioverter-Defibrillators at 2 Academic Medical Centers.
    Leyton-Mange JS, Hucker WJ, Mihatov N, Reynolds M, Albert C, Lubitz SA, Milan DJ.
    JACC Clin Electrophysiol; 2018 Feb 06; 4(2):231-239. PubMed ID: 29749943
    [Abstract] [Full Text] [Related]

  • 52. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671
    [Abstract] [Full Text] [Related]

  • 53. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F, Jarman JW, Clague JR, Till J.
    Heart Rhythm; 2014 Jan 03; 11(1):58-66. PubMed ID: 24120999
    [Abstract] [Full Text] [Related]

  • 54. Post-Shock Asystole in Patients Dying Out of Hospital While Wearing a Cardioverter Defibrillator.
    Berger JM, Sengupta JD, Bank AJ, Casey SA, Sharkey SW, Stanberry LI, Hauser RG.
    JACC Clin Electrophysiol; 2023 Aug 03; 9(8 Pt 1):1333-1339. PubMed ID: 37558289
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M.
    BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD).
    Klein HU, Meltendorf U, Reek S, Smid J, Kuss S, Cygankiewicz I, Jons C, Szymkiewicz S, Buhtz F, Wollbrueck A, Zareba W, Moss AJ.
    Pacing Clin Electrophysiol; 2010 Mar 15; 33(3):353-67. PubMed ID: 19889186
    [Abstract] [Full Text] [Related]

  • 60. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
    Kleemann T, Strauss M, Kouraki K, Zahn R.
    Europace; 2015 Jul 15; 17(7):1068-75. PubMed ID: 25687746
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.